Clinical Practice Guideline

Metabolic Risk Guideline Resources

July 01, 2019

Full Guideline: Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk
JCEM | September 2019 (online July 2019)

James L. Rosenzweig (Chair), George L. Bakris, Lars F. Berglund, Marie-France Hivert, Edward S. Horton, Rita R. Kalyani, M. Hassan Murad, Bruno L. Vergès

The 2019 guideline on metabolic risk:

  • Updates the previous recommendations on this topic from the 2008 guideline – particularly those on elevated lipids and blood pressure – to reflect more recent data.
  • Emphasizes measures to identify and reduce the risk of ASCVD and T2DM, rather than defining the metabolic syndrome as a clinical entity.
  • Focuses on adults between 40 and 75 years of age, for whom a higher quality of evidence exists than for other age groups, thus accruing the greatest impact.



Resources


Essential Points

  • Individuals should be screened for metabolic risk, in five categories:
    1. Elevated waist circumference
    2. Decreased HDL cholesterol
    3. Elevated serum triglycerides
    4. Elevated blood pressure
    5. Elevated blood glucose
  • Three or more categories being abnormal should alert the clinician to a patient’s increased risk for ASCVD and DM (i.e., metabolic risk).
  • We recommend that providers measure waist circumference as part of the initial evaluation. (Note, however, that this does not replace the measurement of weight.)
  • Behavioral change should be the first-line therapy for prevention and should include changes to diet, increased exercise, and weight loss.
  • Persons identified as having metabolic risk should undergo risk scoring to identify the 10-year risk for ASCVD.


List of Recommendations

+ 1.0 Definitions and Diagnosis

+ 2.0 Lifestyle and Behavioral Therapy

+ 3.0 Medical and Pharmacological Therapy

CME

Certified Medical Minute

Watch this expert CME/CE-certified presentation highlighting expert recommendations on the variety of continuous glucose monitoring devices for optimizing management of individual patients with type 1 and type 2 diabetes

Comparison of Available and Emerging CGM Technology

Watch this expert CME/CE-certified presentation highlighting expert recommendations on the variety of continuous glucose monitoring devices for optimizing management of individual patients with type 1 and type 2 diabetes

On the Go

Guideline Pocket Cards

Pocket Guides
Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

Practical quick-reference tools to help you make accurate clinical decisions at the point of care.

Membership

Community Connect

Community Connect is Endocrine Society’s exclusive online community where you can network, talk to experts, join a conversation with people who share your interests, and find what you need throughout your membership journey. Learn, share ideas, and be heard on Community Connect now!

Community Connect is Endocrine Society’s exclusive online community where you can network, talk to experts, join a conversation with people who share your interests, and find what you need throughout your membership journey. Learn, share ideas, and be heard on Community Connect now!

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!